Digital Pathology Market Size, Share, Growth Analysis, By Product(Software {Type [Integrated and Standalone (Information Management System and Image Analysis Software)], By Deployment Mode (On Premises and Cloud Based)}, Scanners (Brightfield Scanners and Other Scanners), Device), By Application(Drug discovery & development, academic research, and disease diagnosis), By Type(Human pathology, Veterinary pathology), By End user(Pharmaceutical and biotechnology, Hospitals & Reference Laboratories, Academic & Research Institutes), By Region - Industry Forecast 2024-2031

Global Digital Pathology Market size was valued at USD 1051.59 million in 2022 and is poised to grow from USD 1133.61 million in 2023 to USD 2067.36 million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

A computer-enabled image-based information platform called "digital pathology" aids in the administration of data produced from digital slides. The rise in cancer incidence, the need for precise diagnosis, and the creation of innovative digital pathology systems by numerous significant players are the main factors propelling the growth of the global digital pathology market Size. A survey released by Medscape suggests that a higher death rate may be linked to chronic illnesses. The increased frequency of cardiovascular illnesses is the primary driver behind the development of sophisticated diagnostic tools. Therefore, the requirement for digital pathology systems grows along with the development of chronic and cardiovascular diseases, propelling the growth of the digital pathology market. 

Technology in digital pathology can benefit a research pipeline in two ways. The first is that macroscopic photographs, tissue microarrays, and whole slide images can be arranged using the designated file storage and viewing software. The creation and use of image analysis methods is the second way that digital pathology is used in research. Additionally, government financing, the expanding use of telepathology solutions in drug development and companion diagnostics, as well as the growing demand for telepathology solutions, which enable pathologists to assess cases remotely and consult worldwide in real-time, are the primary drivers of digital pathology market expansion.